Risk taking in disorders of natural and drug rewards: neural correlates and effects of probability, valence and magnitude by Voon, Valerie et al.
OPEN
Risk-Taking in Disorders of Natural and Drug Rewards:
Neural Correlates and Effects of Probability, Valence, and
Magnitude
Valerie Voon*,1,2,3, Laurel S Morris1,2, Michael A Irvine1,2, Christian Ruck4, Yulia Worbe1,
Katherine Derbyshire5, Vladan Rankov2, Liana RN Schreiber6, Brian L Odlaug7, Neil A Harrison8,
Jonathan Wood3, Trevor W Robbins2, Edward T Bullmore1,2,3 and Jon E Grant5
1Department of Psychiatry, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK; 2Department of Psychiatry, Behavioural and
Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK; 3Cambridgeshire and Peterborough Foundation Trust, Cambridge, UK;
4Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 5Department of Psychiatry and Behavioral Neuroscience,
University of Chicago, Chicago, IL, USA; 6Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA; 7Department of Public
Health, University of Copenhagen, Copenhagen, Denmark; 8Department of Psychiatry, Brighton and Sussex Medical School, Brighton, UK
Pathological behaviors toward drugs and food rewards have underlying commonalities. Risk-taking has a fourfold pattern varying as a
function of probability and valence leading to the nonlinearity of probability weighting with overweighting of small probabilities and
underweighting of large probabilities. Here we assess these influences on risk-taking in patients with pathological behaviors toward
drug and food rewards and examine structural neural correlates of nonlinearity of probability weighting in healthy volunteers. In the
anticipation of rewards, subjects with binge eating disorder show greater risk-taking, similar to substance-use disorders.
Methamphetamine-dependent subjects had greater nonlinearity of probability weighting along with impaired subjective discrimination
of probability and reward magnitude. Ex-smokers also had lower risk-taking to rewards compared with non-smokers. In the anticipation
of losses, obesity without binge eating had a similar pattern to other substance-use disorders. Obese subjects with binge eating also have
impaired discrimination of subjective value similar to that of the methamphetamine-dependent subjects. Nonlinearity of probability
weighting was associated with lower gray matter volume in dorsolateral and ventromedial prefrontal cortex and orbitofrontal cortex in
healthy volunteers. Our findings support a distinct subtype of binge eating disorder in obesity with similarities in risk-taking in the reward
domain to substance use disorders. The results dovetail with the current approach of defining mechanistically based dimensional
approaches rather than categorical approaches to psychiatric disorders. The relationship to risk probability and valence may underlie the
propensity toward pathological behaviors toward different types of rewards.
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INTRODUCTION
Risk evaluation underlies everyday decisions from the
mundane to the more substantial: should I walk today,
switch careers? Risk attitude varies as a function of
probability and valence in a nonlinear fashion thus varying
as a function of context. The pathological use of exogenous
drugs or natural food rewards are behaviors characterized
by the evaluation of risk. The likelihood of obtaining reward
is weighted against the likelihood of punishment in the form
of social or financial losses or poor health. Here we assess
the relationship between risk and the influence of prob-
ability, valence (ie, gain or loss), and magnitude (value)
across pathological behaviors toward drug and food
rewards.
Prospect theory and experimental evidence demonstrate
a fourfold pattern of risk attitude that varies as a function
of the nonlinearity of probability weighting and valence
(Kahneman and Tversky, 2000) (Supplementary Figure S1).
An outcome value is weighted by a decision weight,
w(p), ie, the subjective belief of the objective probability
p. Probability influences risk attitudes. This is because
outcomes with lower probabilities are overweighted and
thus perceived as more probable, leading to risk-seeking for
gains (eg, buying lotteries) and risk aversion for losses of
low probability (eg, buying insurance). On the other hand,
higher probabilities are underweighted, causing risk
aversion for gains and risk-seeking for losses of high
probability. This nonlinearity of probability weighting has
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been associated with anterior cingulate activity (Paulus and
Frank, 2006) and D1 receptor activity (Takahashi et al,
2010). Risk evaluation is also affected by subjective
value, which has a concave function, reflecting dimini-
shing subjective discrimination (marginal sensitivity)
(Supplementary Figure S1). Thus, a d10 increment at a
higher magnitude, d1000 and d1010, has less subjective
value than the same increment at a lower magnitude, d10
and d20.
We focus on risk-taking attitude across disorders of
pathological choice involving natural (obese subjects with
and without binge eating disorder (BED)) and drug rewards
(abstinent alcohol and stimulant dependence). Although
losses in the form of social and health cost are difficult to
model, the secondary reinforcer of money can act as a
proxy. The rodent model of sucrose binge eating has many
similarities with models of substance-use disorders (Avena
et al, 2008), suggesting that the pattern of food intake,
namely binge eating, is a crucial subtype and may
differentiate obese subjects with and without binge eating.
Although preclinical evidence supports similarities between
obesity and substance-use disorders in animal models,
evidence from human studies is limited (Ziauddeen et al,
2012).
Risk-taking abnormalities in disorders of drug and food
reward are known to occur under conditions of risk (known
probabilities) and uncertainty (unknown probabilities). For
example, stimulant-dependent subjects and subjects with
binge eating or obesity have impaired decisions using the
Iowa gambling task, which addresses risk-taking under
uncertainty (Danner et al, 2012; Le Berre et al, 2012).
Chronic amphetamine and alcohol-dependent users show
suboptimal decisions under risk with explicit probabilities,
on the Cambridge gamble task (Rogers et al, 1999;
Chamberlain et al, 2007; Lawrence et al, 2009). Further-
more, subjects with alcohol-use disorders and women with
BED also have impaired decision making on the game of
dice task (Svaldi et al, 2010), with known explicit rules and
probabilities. Although these tasks assess choices under
ambiguous or risky conditions with feedback, they do not
address the influences of valence, probability, or value
differences.
Here we use an adaptation of a risk task (Paulus and
Frank, 2006; Takahashi et al, 2010) that assesses risk
attitude focusing on the effects of valence, probability, and
value, without feedback. We hypothesize that these dimen-
sions influence risk-taking in all disorders and that binge
eating shows similar deficits to other substance-use
disorders. In particular, we expect greater risk-seeking in
the reward domain and that loss has divergent influence on
risk-taking across all disorders. We further investigate the
individual differences of nonlinearity of probability weight-
ing (a) with gray matter volume in healthy volunteers (HV).
PATIENTS AND METHODS
Recruitment
Abstinent subjects with alcohol dependence (EtOH, N¼ 30),
obese subjects (430 body mass index, BMI) with BED
(N¼ 30), obese controls without BED (N¼ 30) and absti-
nent methamphetamine-dependent subjects (Meth, N¼ 23)
were recruited for the study. For each subject in each
patient group, two age- and gender-matched HV were
recruited. For the voxel-based morphometry study, a
different sample of 30 HV (mean age 24.15 (SD 2.91); 17
males) underwent scanning. Further recruitment strategy
and questionnaires completed have been reported elsewhere
(Voon et al, 2013) and are described in Supplementary
Materials.
Task
Subjects chose between a Risky choice (jar with explicit
probability of red and blue balls) and a Sure choice
(Figure 1a). Subjects were told that if they chose the Risky
choice, the computer would randomly select a ball from the
jar. If the ball was red, the subject would win (or lose)
the specified amount indicated above the jar. If they chose
the Sure choice, they would win (or lose) the full amount
indicated. Choices were presented with 4 probabilities
(P¼ 0.1, 0.3, 0.5, 0.9) and 4 expected values (EV¼ d10,
d50, d100, d500) for each probability, giving 16 prospects.
The order of the probabilities and EVs were randomized.
Reward and loss conditions were run separately and the
order counterbalanced across subjects.
For each prospect the certainty equivalent (CE, the
amount of certain money that would be accepted instead
of a gamble) was computed. This was determined in a step-
wise manner depending on the previous choices (Paulus
and Frank, 2006; Takahashi et al, 2010). The value (V) of the
Risky choice (amount indicated over the jar) was calculated
as V¼ EV/P (eg, for P¼ 0.1, EV¼ d100, V¼ d1000)
(Figure 1). The CE range for each prospect was determined
by defining the range of values between 0 and V of the Risky
choice (eg, 0–d1000) (described in detail in Supplementary
Figure S2). In trials 1 and 2, the amount of the Sure choice
was the one-third and two-third cut-point values. The
interval for the next two trials included only the interval
accepted by the subject in the first two trials. For eg, if the
subject rejected the lower and middle third, the upper third
was used as the range for trials 3 and 4. The amount of the
Sure choice was then the one-third and two-third cut-point
values of this upper third range. The same process was
repeated for trials 5 and 6 and the average of these final
choices was used to determine the CE. In the instructions,
subjects were given an example trial of six choices to
demonstrate the step-wise method and changes in the Sure
magnitude. There was no time limit for each trial. The
equivalent in US dollars were used for subjects tested in the
United States. Subjects were told that they would not find
out the outcome after each trial but that at the end of the
study, the computer randomly selected one of the trials and
they would either receive or lose a proportion of the amount
won or lost. The task was coded in e-PRIME 2.0.
The weighted probability, w(p), was calculated according
to prospect theory as:
v x; pð Þ ¼ w pð Þ v xð Þ
where v (x,p) is the subjective value of amount x at
probability p (ie, the CE) and w is the decision weight of the
objective probability p.
The estimation of the nonlinearity of probability weight-
ing was calculated using the two-parameter function derived
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by Prelec (1998). The one-parameter function derived by
Prelec is described as follows:
w pð Þ ¼ exp  ln 1=pð Þf ga
with 0oao1. Using the one-parameter function, the w(p)
function is an inverted S-shaped function with a fixed
inflection point at p¼ 1/e¼ 0.37 (where p¼ p(w)).
The a parameter indicates the degree of nonlinearity with
a approaching 0 indicating greater nonlinearity and a
approaching 1 approximating the linear expected value. As
we were focusing on pathological groups in which the
inflection point may not conform to 1/e, we estimated pro-
bability weighting using a two-parameter function (Prelec,
1998) in which the inflection point was not constrained to
the 1/e fixed value:
w pð Þ ¼ exp  b  ln pð Það Þ
b indicates the net convexity of the curve. Where b¼ 1 is
consistent with the one-parameter function where the
inflection point crosses at p¼ 1/e. As b approaches 0, the
inflection point at which risk-seeking shifts to risk aversion
increases occurring at p41/e, indicating greater risk-
seeking across a wider range of probabilities. Examples of
functions with different a and b values are shown in
Figure 1. a and b and the fit R2 were calculated for each EV.
R2 outliers (43 SD from group mean) were removed from
the analysis.
Statistical Analysis
The w(p) was analyzed as a mixed measures ANOVA with
Group as a between-subjects factor, and Valence, Prob-
ability, and Value as a within-subjects factor. We focused
on the main effects and the interaction effects involving
the Group factor. We also conducted a post hoc analysis
comparing Group differences as a function of probability
using Tukey’s test if there was a Group Probability
Valence interaction to assess the influence of probability.
To assess the relationship with Value, we conducted two
separate mixed measures ANOVA since Value was positive
in the reward domain and negative in the loss domain.
We also conducted a post hoc analysis using Tukey’s test
if there was a GroupValue interaction to assess the
influence of value.
The w(p) for each value for the reward condition were fit
with the two-parameter model and a and b analyzed as a
mixed measures ANOVA with Group as a between-subjects
factor and value as a within-subjects factor. For all analyses,
Po0.05 was considered significant.
We also assessed the relationship of w(p) for reward and
loss collapsed across probability and value to clinical
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Figure 1 (a) Risk task. Subjects chose between a gamble and sure choice in both reward and loss conditions across 4 probabilities (0.1, 0.3, 0.5, 0.9) and 4
expected values (d10, d50, d100, d500). A staircase procedure was used to estimate the gamble’s certainty equivalents (amount of sure payoff in subject
indifferent between sure payoff and gamble). (b) Examples of functions with different nonlinear (a) and convexity (b) values. (c) Probability weighting, w(p),
data of healthy volunteers (HV) in reward condition as a function of objective probability, p. The dotted line represents certainty equivalence¼ expected
value. (d) Regression analysis of gray matter volume and a. The regression represents left ventromedial prefrontal cortex as a function of a.
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measures for each subject group using the Pearson
correlation. For the BED and obese subjects, the corrected
Bonferroni value was Po0.0125 (4 comparisons) and for
EtOH and Meth subjects was Po0.008 (6 comparisons).
MRI data acquisition and analysis details are reported in
Supplementary Materials.
RESULTS
Subject Characteristics
Subject characteristics are reported in Supplementary
Materials S1 and S2. Three HV, one BED, one EtOH, and
two Meth subjects were removed from the analysis as outliers.
For each subject group, the following analyses are divided
into: (i) decision weight w(p) across probabilities
(Supplementary Table S3; Figure 2); (ii) w(p) separately
for reward and loss across values (Supplementary Table S4;
Figure 3 and Figure 4); (iii) nonlinearity, a, and convexity, b
Supplementary Table S5; Figure 5).
Obese Subjects with BED
Decision weight, w(p): probability. A main Group effect
revealed that BED overweighted probabilities compared
with HV. The GroupValence interaction showed greater
risk-taking in reward (mean difference  0.100 (SEM 0.03)
(95% CI:  0.161 to  0.039), p¼ 0.002) but not loss (0.020
(SEM 0.034) (95% CI:  0.047–0.087), p¼ 0.553). There was
a main Probability and Value effect and Group
Probability and Group ProbabilityValence interactions.
On post hoc analysis, BED made more risky choices to
moderate probabilities (P¼ 0.30 and 0.50) in reward and
more risky choices to high probabilities (P¼ 0.90) in loss.
Decision weight, w(p): value. Reward: there was a main
Group, Probability, and Value effect. There was a Group
Value interaction in which there was a Value effect in HV
(F(3,86)¼ 12.036, po0.001) but not in BED (F(3,86)¼
1.199, p¼ 0.315). Loss: there was a main Probability and
Value effect only.
Reward nonlinearity (a) and convexity (b). For b, there
was a main Group effect: BED made more risky choices
(lower b) compared with HV (R2: HV 0.57 (0.39), BED 0.51
(0.33), t¼ 0.51, p¼ 0.59). There was a main Probability
effect. For a, there was a main Probability effect.
Obese Controls Without BED
Decision weight, w(p): probability. There was a main
Probability, Value, and Valence effect and a Group
Probability and Group ProbabilityValence effect. On
post hoc analysis, during loss, obese controls made fewer
risky choices to low probabilities (P¼ 0.10 and 0.30) and
more risky choices to high probabilities (P¼ 0.90).
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Figure 2 Probability weighting in pathological disorders in reward and loss conditions. The graphs compare probability weighting, w(p), in obese subjects
with binge eating disorder (BED) and without BED (obese controls), abstinent alcohol-dependent (EtOH) and abstinent methamphetamine-dependent
(Meth) vs their own age- and gender-matched controls for reward (top) and loss (bottom) conditions. The dotted line represents certainty equivalence¼
expected value. Error bars represent SEM. *Post hoc analysis results following interaction effect of GroupValence Probability. Details of significant
differences are described in the text and Supplementary Table S3. P¼ probability.
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Decision weight, w(p): value. There was a main Prob-
ability and Value effect. During loss, there was a main
Probability and Value effect.
Reward nonlinearity (a) and convexity (b). For b and a,
there was a main Probability effect but not of Group or an
interaction. (R2: HV 0.56 (0.40), obese 0.47 (0.41), t¼ 1.154,
p¼ 0.253.)
Abstinent Alcohol-Dependent Subjects
Decision weight, w(p): probability. A main Group effect
revealed that EtOH subjects overweighted probabilities
compared with HV in reward (mean difference  0.074
(SEM 0.033) (95% CI:  0.139 to  0.010), p¼ 0.025) but
not in loss (mean difference  0.015 (SEM 0.032) (95%
CI:  0.078–0.048), p¼ 0.639). There was a main Probability
and Value effect and Group Probability and Group
ProbabilityValence interaction. On post hoc analysis,
EtOH subjects made more risky choices to moderate
probabilities (P¼ 0.50) to reward and to high probability
(P¼ 0.90) to loss along with fewer risky choices to low
probability (P¼ 0.10) to loss.
Decision weight, w(p): value. Reward: there was a main
Group, Probability, and Value effect. Loss: there was a main
Probability effect.
Reward nonlinearity (a) and convexity (b). For b, there
was a main Group effect: EtOH made more risky choices
(lower b) compared with HV (R2: HV 0.53 (0.40), EtOH 0.56
(0.26), t¼  0.35, p¼ 0.72). There was a main Value effect.
For a, there were no main or interaction effects.
Abstinent Stimulant-Dependent Subjects
Decision weight, w(p): probability. A main Group effect
demonstrated that Meth subjects overweighted probabilities
compared with HV in reward (mean difference  0.97
(SEM 0.038) (95% CI:  0.172 to  0.022), p¼ 0.012)
and not in loss (mean difference¼ 0.029 (SEM 0.035) (95%
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Figure 3 Left: probability weighting as a function of current smokers, ex-smokers, and non-smokers in healthy volunteers (HV), and obese subjects with
and without binge eating disorder. *Po0.05 Group difference between ex-smokers and non-smokers. Right: relationship with clinical variables. Obese
subjects with binge eating disorder: relationship between binge eating severity (BES) and probability weighting, w(p), in the reward and loss domains.
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Figure 4 Probability weighting as a function of reward value. The graphs compare probability weighting, w(p), and value in the reward domain in obese
subjects with binge eating disorder (BED) and without BED (obese controls), abstinent alcohol-dependent (EtOH) and abstinent methamphetamine-
dependent (Meth) subjects vs their own age- and gender-matched controls. Error bars represent SEM. *GroupValue interaction. Details of significant
differences are described in the text and Supplementary Table S4. HV, healthy volunteers; Stim, abstinent stimulant dependent.
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CI:  0.099–0.041), p¼ 0.413). There was a main Probability
effect and Group Probability and GroupValue interac-
tion. On post hoc analysis, Meth subjects made more risky
choices to low probability (P¼ 0.10 and 0.30) in reward and
to high probability (P¼ 0.90) in loss along with fewer risky
choices to low probability (P¼ 0.10) in loss.
Decision weight, w(p): value. Reward: there was a main
Group, Probability, and Value and GroupValue interac-
tion effect in which Value was significantly different in HV
(F(3,65)¼ 7.207, po0.001) but not in Meth (F(3,65)¼ 1.560,
p¼ 0.206). Loss: there was a main Group and Probability
effect only.
Reward nonlinearity (a) and convexity (b). For b, there
was a main Group effect: Meth made more risky choices
(lower b) compared with HV (R2: HV 0.52 (0.40), Meth 0.40
(0.37), t¼ 1.31, p¼ 0.19). There was an interaction effect.
For a, there was a Group effect: Meth had greater
nonlinearity (lower a) compared with HV. There was a
main effect of Value.
Nicotine
Although the study was not intended to address nicotine
effects, analyses were conducted on an exploratory basis
focusing on w(p) for probability (Supplementary Materials).
Ex-smokers (N¼ 25) in the combined group of obese,
BED, and HV, made fewer risky choices than non-smokers
(N¼ 82) (F(1,103)¼ 4.276, p¼ 0.041), with no differences
between current smokers (N¼ 24) and non-smokers
(N¼ 82) (F(1,102)¼ 1.471, p¼ 0.228) (Figure 3).
Relationship to Clinical Measures
We also assessed the relationship of w(p) to clinical
measures. For BED only, BES scores were positively
correlated with w(p) for reward (Pearson’s correlation
coefficient¼ 0.498, p¼ 0.007) and negatively correlated for
loss ( 0.509, p¼ 0.006) (Bonferroni-corrected P40.0125)
(Figure 3). There were no correlations with BMI. For EtOH,
there was a negative correlation trend between weeks
abstinent and w(p) for reward ( 0.417, p¼ 0.024) but not
loss (0.036, p¼ 0.850). There were no significant correla-
tions with duration or total units (Bonferroni-corrected
P40.008). For Meth there was a negative correlation trend
with number of years of heavy use and w(p) for reward
( 0.487, p¼ 0.022) but not loss (0.143, p¼ 0.523) (Bonfer-
roni-corrected P40.008). There were no significant correla-
tions between w(p) and BDI for any group (p40.05).
Structural Correlates of Nonlinearity
In 30 HV, gray matter volume was positively correlated with
a in the right dorsolateral prefrontal cortex (DLPFC)
(reported in MNI coordinates x y z in mm¼ 33 50 36,
cluster size¼ 18, Z¼ 5.18, whole-brain FWE-corrected
P¼ 0.009, BA 9), left ventromedial prefrontal cortex
(vmPFC) (x y z in mm:  4 44  18, cluster size¼ 33,
Z¼ 4.94, whole-brain FWE-corrected P¼ 0.02, BA 11,
Figure 1d) and right medial orbitofrontal cortex (mOFC)
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Figure 5 Convexity (b) and nonlinearity (a). The graphs compare convexity (b; top) and nonlinearity (a; bottom) in obese subjects with binge eating
disorder (BED) and without BED (obese controls), abstinent alcohol-dependent (EtOH) and abstinent methamphetamine-dependent (Meth) subjects vs
their own age- and gender-matched controls. Error bars represent SEM. *Main Group effect. Details of significant differences are described in the text and
Supplementary Table S5. HV, healthy volunteers; Stim, abstinent stimulant dependent.
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(x y z in mm: 15 30  18, cluster size¼ 17, Z¼ 4.98, whole-
brain FWE-corrected P¼ 0.02, BA 11).
DISCUSSION
We demonstrate that risk attitude across disorders of
addiction varies according to the currently manipulated
dimensions of valence (gain and loss), probability, and
value (magnitude). In the reward domain, obese subjects
with binge eating have enhanced risk-seeking similar to that
of substance-use disorders, with the degree of risk-seeking
in the reward domain correlating with binge eating severity.
In contrast, in the loss domain, obese subjects without
binge eating have a similar risk attitude to substance-use
disorders with greater risk aversion to unlikely large losses
and greater risk-seeking to likely small losses. On the
influence of value, obese subjects with binge eating also
have a similar impairment to that of the Meth subjects,
particularly in their discrimination of subjective value.
These findings further explain the abnormalities in risk-
taking observed in obese individuals (Pignatti et al, 2006),
and more importantly highlight the similarities in disorders
characterized by natural and drug rewards. In terms of
probability, methamphetamine-dependent subjects have
greater risk-seeking to unlikely but large rewards along
with greater nonlinearity of probability weighting (lower a),
and BED and alcohol-dependent subjects have greater risk-
seeking to more likely but smaller rewards. Although not a
direct correlate, this differential attitude toward reward
probability may underlie choice tendencies toward the degree
of risk or ‘high’ of illegal or legal drugs or natural rewards.
These tendencies may combine with enhanced ‘waiting’
impulsivity in the alcohol- and methamphetamine-dependent
subjects (Voon et al, 2014a) to drive risky decisions in
pathological choices toward natural and drug rewards.
The relationship between obesity and disorders of
substance addiction has recently been of great interest. In
keeping with the preclinical literature on sugar bingeing in
rodents, binge eating, rather than obesity per se, may have
closer overlaps with substance-use disorders. In rodents,
sugar bingeing reflects addictive-like properties including
enhanced responding for sugar after abstinence, ampheta-
mine cross-sensitization and nucleus accumbens dopamine
release (Avena et al, 2008). In humans, food stimulation
in BED subjects is also associated with greater striatal
dopamine release (Wang et al, 2011). Thus, our data on risk
attitude in the reward domain dovetails with these
observations suggesting similarities in enhanced risk-
seeking between binge eating and substance dependence.
In the context of loss, obese subjects without BED and
alcohol- and stimulant-dependent subjects are all more risk
averse to low probability losses and more risk-seeking to
high probability losses. These results might explain the
coexistence of conflicting risk attitudes influenced by
context: risky addictive behaviors to avoid likely small
negative outcomes and simultaneously, risk aversion in the
anticipation of unlikely large negative outcomes. Our
finding of enhanced sensitivity to loss anticipation dovetails
with heightened sensitivity to negative cues (such as
negative mood, stress, or withdrawal), which may act as a
negatively reinforcing motivator in substance-use disorders
and compulsive overeating (Koob and Volkow, 2010). As
expected in HV, normal responses to loss are demonstrated
by risk aversion to low probability losses and risk-seeking to
higher probability losses. Our findings in the pathological
groups suggest an enhancement of this underlying tendency.
Whereas previous tasks involved feedback, our current
task focuses on risk anticipation without feedback empha-
sizing the predictive nature of risk anticipation. In a study
focusing on risk-taking under uncertainty using the Iowa
gambling task, both BED and obese controls were equally
impaired (Danner et al, 2012). In contrast, in a study
focusing on explicit risk using the game of dice task, BED
had greater risk-taking relative to obese controls (Svaldi
et al, 2010). Our results are convergent with these findings
suggesting that BED may be impaired at risky choices under
risk and ambiguity but obese subjects without BED may
be impaired only under ambiguity. The impairment
under ambiguity in BED has been shown to be related to
depression (Muller et al, 2014). Studies in substance-use
disorders have similarly demonstrated risk-taking abnorm-
alities in tasks with both ambiguity and explicit risk (Rogers
et al, 1999; Chamberlain et al, 2007; Lawrence et al, 2009;
Danner et al, 2012; Le Berre et al, 2012). Unlike this current
study, these previous studies do not address differences in
probability, valence, or value.
We show that enhanced nonlinearity of probability
weighting (lower a) in HV is associated with lower gray
matter volume in left vmPFC, right mOFC, and right
DLPFC, consistent with regions implicated in the represen-
tation and evaluation of risk and probability (Fellows and
Farah, 2007; Tom et al, 2007; Rangel et al, 2008). Greater
nonlinearity of probability weighting is believed to be
associated with impaired discrimination of different pro-
babilities (Takahashi et al, 2010), which dovetails with our
findings of decreased gray matter volume in the vmPFC and
OFC. The curvature of the weighting function has been
postulated to be related to the psychophysics of diminishing
sensitivity or affective influences such as hope or fear
related to the gamble (Trepel et al, 2005). We further show
that Meth subjects have greater nonlinearity of probability
weighting (lower a, ie, overweighting of low probabilities
and underweighting of high probabilities) to anticipated
risky rewards. Methamphetamine dependence has been
associated with decreased OFC volume (Nakama et al, 2011)
possibly related to comorbid nicotine use (Morales et al,
2012). Abstinent stimulant-use disorder subjects have also
been shown to have decreased mOFC volumes (Franklin
et al, 2002), associated with impaired decisions in a
modified gambling task (Tanabe et al, 2009). Although we
did not show abnormalities in a in BED subjects, OFC-
volume differences have also been reported (Schafer et al,
2010; Voon et al, 2014b).
Subjective value was assessed by comparing the w(p)
across the highest and lowest values within each group. As
expected, HV exhibited a decrease in subjective value
equivalent to diminishing marginal sensitivity with increas-
ing objective value (Kahneman and Tversky, 2000). BED
and Meth subjects did not demonstrate any differences in
subjective value with increasing objective value. This can be
interpreted as decreased sensitivity toward changes in
magnitude, which coincides with reports of decreased
sensitivity to changes in value in stimulant users. Psychos-
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timulant-dependent subjects show decreased subjective
discrimination of monetary reward gradients (Goldstein
et al, 2007a), and decreased reaction times and lateral
orbitofrontal responsivity to monetary reward outcomes
(Goldstein et al, 2007b).
Although exploratory, we show that ex-smokers had
lower risk-taking in the reward domain than non-smokers.
These findings suggest either that the lack of nicotine is
associated with lower risk-taking or more likely, that the
ability to stop smoking may be related to lower risk-taking
tendencies. In the case of obese ex-smokers, lower risk-
taking for rewards may also reflect the shift from exogenous
nicotine drug use toward endogenous natural rewards.
There were several limitations to the study. Relative to
HV, Meth, BED, and EtOH subjects had higher depression
scores as commonly reported in studies on substance-use
disorders and in relation to this current cohort (Voon et al,
2013). However, we show that IQ and depression scores are
unrelated to the current measures. As this is a cross-
sectional study, we cannot address the question of whether
risk attitude is a state or trait-related factor. Unlike subjects
with substance-use disorders, the obese subjects were not
‘abstinent’ or food restricted, which may affect motivational
states. The influence of food restriction is baseline
dependent such that it decreases risk aversion in those
who are risk-seeking and increases risk-seeking in those
who are risk averse (Levy et al, 2013). How food restriction
might affect obese subjects should be assessed. We use a
similar secondary reinforcer across all groups to allow for
comparisons. The use of primary reinforcers are indicated
to assess any differential influence on risk-taking.
We show that risk-taking is heterogeneous and patholo-
gical choices can be influenced by factors of valence,
probability, and magnitude. Our data uniquely highlight
the overlaps between the behavior of binge eating and
substance-use disorders in the reward domain and obesity
and substance-use disorders in the loss domain. BED
subjects similar to stimulant disorder subjects were also
impaired in discrimination of subjective value. These
characterizations are of particular importance as we have
recently shown that an expected risk factor of ‘waiting’
impulsivity is not disturbed in obese patients with and
without BED (Voon et al, 2014a). Our findings support
mechanistically based dimensional rather than categorical
approaches to psychiatric classifications (Insel et al, 2010)
and suggest valence-specific modification of risk perception
as a potential therapeutic avenue.
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